Bellevue, Washington Clinical Trials

*Healthy Children Studies

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Alzheimer's Disease

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects with Dementia of the Alzheimer’s Type

Northwest Clinical Research Center

A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF GANTENRUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE

Northwest Clinical Research Center

A randomized, double-blind, placebo-controlled, twocohort parallel group study to evaluate the efficacy of CAD1 06 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer's disease

Anemia

Research Site Updated

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Atrial Fibrillation

Overlake Hospital

A clinical study for patients with Persistent Atrial Fibrillation or Paroxysmal Atrial Fibrillation

Overlake Hospital Medical Center

Patients are needed to participate in a clinical research study evaluating Mobile Application Intervention and Rivaroxaban for the treatment of Atrial Fibrillation

Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Northwest Clinical Research Center

A clinical trial to evaluate treatments using EVO for patients with Attention Deficit Disorder With Hyperactivity

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD)

Northwest Clinical Research Center

A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-dose Safety and Efficacy Study of SPD489 Compared with Placebo in Preschool Children Aged 4-5 Years with Attention-deficit/Hyperactivity Disorder

Northwest Clinical Research Center

A randomized, controlled parallel-group, intervention study to assess at-home, game-based digital therapy for treating pediatric patients participants ages 8 to 12 years old with Attention Deficit Hyperactivity Disorder (ADHD)

Research Center New

Study for Pediatric ADHD

Autism

Northwest Clinical Research Center

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, 52-WEEK EFFICACY AND SAFETY STUDY OF RO5285119 IN ADULTS WITH AUTISM SPECTRUM DISORDERS (ASD) WITH A 2-YEAR OPEN LABEL EXTENSION

Northwest Clinical Research Center

A PHASE II MULTI-CENTER, RANDOMIZED, DOUBLEBLIND, 24-WEEK, 3-ARM, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RO5285119 IN CHILDREN AND ADOLESCENTS AGE 5-17 WITH AUTISM SPECTRUM DISORDER (ASD)

View More »

Northwest Clinical Research Center

A clinical trial seeking patients for a research study for the treatment of Autism Spectrum Disorder

Bipolar Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Breast Cancer

Overlake Medical Center

A clinical research study of paclitaxel, Reparixin and placebo for the treatment of Metastatic Breast Cancer, Triple-Negative Breast Cancer

Chronic Pain

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

View More »

Research Site

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Complex Regional Pain Syndrome- type 1 (CRPS-I)

Northwest Clinical Research Center

Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

COPD (Chronic Obstructive Pulmonary Disease)

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Research Site Updated

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Depression

MMG

Does Your Child Have Depression?

View More »

Research Site

A clinical trial to evaluate treatments using AXS-05 and Bupropion for patients with Treatment Resistant Major Depressive Disorder

Forest Investigative Site 001

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 001

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Northwest Clinical Research Center Updated

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

NorthWest Clinical Research Center

A clinical trial to evaluate treatments using Rapastinel and Placebo for patients with Depressive Disorder, Major

NorthWest Clinical Research Center

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

NorthWest Clinical Research Center

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Northwest Clinical Research Center

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Depression (Pediatric)

Northwest Clinical Research Center

A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder

Depression (Treatment-Resistant)

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Northwest Clinical Research Center

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Diabetes (Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus

Northwest Clinical Research Center

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age

Diabetes Mellitus, Type 2

Northwest Clinical Research Center

A clinical research study of Dulaglutide and Placebo for the treatment of Type 2 Diabetes

Dyskinesias

Neurocrine Clinical Site

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Dyslipidemia

Research Site Updated

A clinical research study for the treatment of Medical Conditions to be Studied, Dyslipidemia or ASCVD Management

Glaucoma

Specialty Eye Care

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Attack (Myocardial Infarction)

Novartis Investigative Site

A Phase 3 clinical study for patients with Acute Myocardial Infarction

Hemodialysis

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Hernia

Overlake Hospital

A clinical study for patients with Hernia, Ventral or Incisional Hernia

High Blood Pressure (Hypertension)

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Inflammatory Bowel Disease

Research Site Updated

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Kidney Disease

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Lung Disease

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Macular Degeneration

Vitreoretinal Associates of Washington

A Phase 3 clinical study for patients with Geographic Atrophy

Mental Disability

Research Center New

Study for Pediatric ADHD

Migraine (Adult)

Northwest Clinical Research Center

Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (rimegepant) for the Acute Treatment of Migraine

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Migraine (Pediatric)

Northwest Clinical Research Center

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents.

Migraine and Cluster Headaches

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 with a Long-Term Open-Label Extension in Patients with Chronic Cluster Headache

Northwest Clinical Research Center

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE

Northwest Clinical Research Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headaches

Neurologic Disorders

Research Center New

Study for Pediatric ADHD

Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Osteoarthritis

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED STUDY TO CONFIRM THE EFFICACY OF AN INTRA- ARTICULAR INJECTION OF AMPION™ IN ADULTS WITH PAIN DUE TO SEVERE OSTEOARTHRITIS OF THE KNEE

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-controlled trial to assess the efficacy and safety of AXS-02 (disodium zoledronate tetrahydrate) administered orally to subjects with knee osteoarthritis associated with bone marrow lesions.

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

View More »

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study of Investigational Medical Product (IMP) administered in parent study to evaluate Osteoarthritis

Parkinson's Disease

Northwest Clinical Research Center

Effect of LY3154207 on Cognition in Mild-to-Moderate Parkinson’s Disease Dementia (PDD)

Postherpetic Neuralgia

Northwest Clinical Research Center

A double-blind, placebo-controlled, randomized dose ranging trial to determine the safety and efficacy of three dose levels of EMA401 in reducing 24-hour average pain intensity score in patients with post-herpetic neuralgia (EMPHENE)

Post-Partum Depression

Northwest Clinical Research Center

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF SAGE-217 IN THE TREATMENT OF ADULT FEMALE SUBJECTS WITH SEVERE POSTPARTUM DEPRESSION

Schizophrenia and Schizoaffective Disorders

Northwest Clinical Research Center

A phase II randomised, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia

Northwest Clinical Research Center

A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia

Northwest Clinical Research Center

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, 52-WEEK EFFICACY AND SAFETY STUDY OF RO5285119 IN ADULTS WITH AUTISM SPECTRUM DISORDERS (ASD) WITH A 2-YEAR OPEN LABEL EXTENSION

View More »

Alkermes Investigational Site

Patients are needed to participate in a clinical research study of ALKS 3831 and Olanzapine to evaluate Schizophrenia

Tardive Dyskinesia

Northwest Clinical Research Center

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

View More »

Neurocrine Clinical Site

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Northwest Gastroenterology Associates

A Phase 3 clinical study for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Northwest Gastroenterology Associates /ID# 163629

A Phase 2 clinical study for patients with Ulcerative Colitis (UC)

Ulcers

Northwest Gastroenterology Associates

A Phase 3 clinical study for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Northwest Gastroenterology Associates /ID# 163629

A Phase 2 clinical study for patients with Ulcerative Colitis (UC)